Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Supervalu Pharmacies Inc (NPI 1184700049)

Field	Value
Entity Type	Organization
Organization	Supervalu Pharmacies Inc
Address	421 3rd St S
City	Stillwater
State	MN
ZIP	55082
Taxonomy	Community/Retail Pharmacy
NPI Enumerated	October 31, 2006

Payer Source	Total Paid
Medicare	$3.5M
Medicaid	$0

Key Findings

SUPERVALU PHARMACIES INC presents as a high-volume community/retail pharmacy primarily delivering immunizations and COVID services: its top Medicare revenue drivers are vaccine-related codes 91322 (6.8K claims, $973.8K revenue), 90662 (11.4K claims, $789.7K revenue) and 91320 (3.7K claims, $467.2K revenue), and it also reports large volumes of testing via K1034 (36.6K claims, $365.8K revenue). Administration codes G0008 (12.6K claims, $352.9K revenue) and 90480 (10.5K claims, $324.2K revenue) further indicate that onsite vaccine administration is a core operational activity rather than only product dispensing.

Revenue concentration is pronounced: the provider reports total Medicare revenue of $3.5M and its precomputed top-3 Medicare codes account for 63.8% of that Medicare revenue, indicating most Medicare dollars are driven by a small set of vaccine products and related administration/testing services. This concentration suggests material sensitivity in overall revenue to changes in vaccination demand or reimbursement for those specific codes.

Payer mix is effectively single-payer on file: Medicare accounts for reported activity ($3.5M lifetime Medicare revenue) while there is no Medicaid billing on file, so this entity operates with virtually no Medicaid footprint according to available claims. That absence should be treated as an intentional operational/billing pattern or a limitation in the dataset when assessing Medicaid network participation.

The provider’s competitive standing on vaccine-related codes is nationally prominent: 91322 ranks #11 of 29357 providers nationally (100th percentile; extreme outlier), 90662 ranks #12 of 70752 providers nationally (100th percentile; extreme outlier), and 91320 ranks #13 of 27083 providers nationally (100th percentile; notably above typical national volume). Multiple other administration and vaccine codes (e.g., G0008, 90480, 90480 ranks #13 of 46950 providers nationally) are also in the 100th percentile or flagged as extreme outliers, consistent with a dominant national presence for specific immunization services.

While some codes show extreme national outlier status, not all activity is atypical: K1034 (36.6K claims, $365.8K revenue) ranks #232 of 30143 providers nationally (99th percentile; typical, unremarkable volume) and several pneumococcal and flu formulations (e.g., 90677, 90686, G0009) are characterized as typical or unremarkable in absolute volume despite contributing material incremental revenue. This mix indicates the provider combines exceptionally high throughput on certain product lines with broader, more standard immunization offerings.

Operationally, the claims and revenue mix points to a high-throughput retail vaccination hub: multiple distinct flu vaccine codes (90662, 90686, 90682, 90688) and pneumococcal vaccine 90677 appear on the top-25 list, with 90662 alone contributing $789.7K (22.6% of Medicare revenue). High counts of administration codes (G0008, 90480) alongside product codes suggest a staffed immunization workflow rather than passive dispensing.

The provider’s tenure in the NPI file (enumerated 2006-10-31, ~20 years ago) indicates an established presence in the Medicare billing ecosystem; paired with the extreme outlier ranks on core vaccine codes, this longevity supports interpretation of sustained, built-out vaccination operations rather than a transient billing spike. Analysts should interpret historic presence plus concentrated vaccine volumes as evidence of a stable service line.

From a payer strategy and network perspective, the combination of concentrated Medicare revenue and no Medicaid billing on file means this entity will look like a Medicare-dominant immunization partner. For payers evaluating capacity or access to vaccination services, SUPERVALU’s code-level dominance in several vaccine lines (as noted above) signals it is a major provider of immunizations to the Medicare population but offers limited observable Medicaid engagement.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

14 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
91322	This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL.	6,810	$140	$973.8K
90662	This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection…	11,450	$70	$789.7K
91320	This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL.	3,650	$130	$467.2K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	36,580	$10	$365.8K
G0008	Administration of influenza virus vaccine	12,600	$30	$352.9K
90480	The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19.	10,460	$30	$324.2K
90677	This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the…	290	$280	$81.2K
0124A	N/A	1,540	$40	$60.1K
0134A	N/A	1,060	$40	$41.5K
90686	This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL…	1,010	$20	$22.2K

Showing 1–10 of 14

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

Supervalu Pharmacies Inc — 13 of 14 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

14 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
91322	1	830	30	$140	$12.8K
91320	2	690	30	$130	$11K
K1034	1	460	590	$10	$9.6K
90677	1	730	20	$280	$5.6K
90662	1	940	30	$70	$5K
90480	1	1,380	30	$40	$3.5K
G0008	1	2,300	30	$30	$2.2K
90682	1	40	10	$70	$1.4K
0134A	1	300	20	$40	$1.4K
0124A	1	620	20	$40	$1.2K

Showing 1–10 of 14

Nearby Providers

Other providers in the same ZIP code as Supervalu Pharmacies Inc, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Washington County Community Services	MN	Case Management Agency	$0	$38.3M
Bluestone Physician Services, P.A.	MN	Family Medicine Physician	$0	$26.9M
Reflections	MN	Addiction (Substance Use Disorder) Counselor	$0	$14.4M
Cedar Ridge Treatment Center LLC	MN	Substance Abuse Rehabilitation Facility	$0	$10.4M
Alan Downie	MN	Ophthalmology Physician	$1M	$0
Associated Eye Care Ambulatory Surgery Center LLC	MN	Ophthalmologic Surgery Clinic/Center	$834.9K	$0
April Abrahamson	MN	Internal Medicine Physician	$307.2K	$0
David Park	MN	Ophthalmology Physician	$193.3K	$0
Adam Goddard	MN	Ophthalmology Physician	$176.6K	$0
Charles O'hare	MN	Family Medicine Physician	$164K	$0

Supervalu Pharmacies Inc — Billing Profile & Reimbursement Data

Sign up for Supervalu Pharmacies Inc — Billing Profile & Reimbursement Data policy alerts

Supervalu Pharmacies Inc — Billing Profile & Reimbursement Data

Sign up for Supervalu Pharmacies Inc — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References